PendingPromise
First clinical trials of its AI-designed drugs by end of 2026
“Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.”
Context: Hassabis at Davos, as reported by Reuters (via CNA, Jan 20, 2026).
How we judge it
Our interpretation: Isomorphic Labs starts a human clinical trial of one of its drug candidates by 31 Dec 2026.
Resolution criteria are our interpretation of the claim, written before grading. Methodology
- Said
- Resolve by
- Due in 84 days
- Verdict
- Pending
- Stated probability
- None stated
- Specificity
- 3 of 3 (precise and measurable)
